Precision Medicine Strategic Considerations for Global Market Access: From Early CDx Development to Clinical Trials & Overcoming Regulatory Hurdles

Time: 8:30 am
day: Conference Day 1 AM

Details:

  • Understanding regulatory considerations for USA, EU and APAC to expedite approvals
  • Creating a robust CDx strategy to expedite from clinical trials through to CDx launch
  • Key considerations for diagnostic tests in clinical trials and using this data for global submissions

Speakers: